logo-loader
viewdorsaVi

US expansion represents huge opportunity in a growing market for DorsaVi

We are all familiar with wearable technology such as Fitbit and the Apple Watch, but wearable technology has uses far beyond organising our live and tracking our exercise.

DorsaVi (ASX:DVL) has a range of revolutionary wearable sensor technology that is used in workplaces to reduce worker injuries, in clinical settings and in the field of sports performance.

"We wanted to capture the exact way people move... we've got FDA cleared wearable sensors that give expert information to the people who use them. Our two main markets are in the clinical market, it might be with physiotherapists or orthopaedic surgeons using it in their clinical world, or in the workplace market, where you're able to understand how people move in the workplace and where the risks are coming from, and what they may be able to do to reduce those risks," explains DorsaVi CEO Andrew Ronchi.

There is a trend towards prevention of worker injury rather than treatment of problems after they occur and DorsaVi is leading the way in the field with its movement analysis products.

Quick facts: dorsaVi

Price: 0.043 AUD

ASX:DVL
Market: ASX
Market Cap: $8.77 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Shekel Brainweigh progresses Hitachi Europe R&D and...

Shekel Brainweigh Ltd (ASX:SBW) country manager for Australia Danny Nadri updates Proactive on progress with its signed Hitachi Europe R&D and commercial collaboration agreement.  The automation joint development and marketing agreement is for first-of-its-kind autonomous retail...

1 day, 19 hours ago

2 min read